PARDES BIOSCIENCES, INC. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2021 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Pardes Biosciences, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2021 to Q2 2023.
  • Pardes Biosciences, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2023 was $1.4M, a 64% decline year-over-year.
  • Pardes Biosciences, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2023 was $8.88M, a 40.3% increase year-over-year.
  • Pardes Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $10.6M, a 765% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $8.88M $1.4M -$2.49M -64% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-04
Q1 2023 $11.4M $2.34M +$811K +53.1% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-05
Q4 2022 $10.6M $2.43M +$1.86M +325% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-14
Q3 2022 $8.7M $2.72M +$2.37M +690% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $6.33M $3.89M +$3.66M +1590% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 $2.67M $1.53M +$1.45M +1909% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q4 2021 $1.22M $571K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-14
Q3 2021 $344K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 $230K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $76K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.